Newsroom | 24448 results
Sorted by: Latest
-
Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting
ATLANTA--(BUSINESS WIRE)--Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec and Dosimetry Services will be introduced alongside innovations from the broader Mirion portfolio, including...
-
Venuiti Health Launches Powerful New Conformance Suite to Advance Digital Healthcare in Canada
WATERLOO, Ontario--(BUSINESS WIRE)--Venuiti Healthcare launches Conformance Suite to simplify health-tech compliance, boost transparency, and enable interoperability across Canada....
-
ZAP Surgical anuncia los primeros tratamientos con la plataforma ZAP-X Gyroscopic Radiosurgery en Latinoamérica
SAN CARLOS, California--(BUSINESS WIRE)--ZAP Surgical Systems, Inc. líder mundial en cirugía cerebral robótica no invasiva, anunció hoy los primeros tratamientos de pacientes utilizando su plataforma ZAP-X® Gyroscopic Radiosurgery® en Latinoamérica. Ubicada en Neuland, Boquerón, Paraguay, Radioterapia Concordia (www.saludconcordia.com) ha comenzado oficialmente su uso clínico, marcando un hito importante en la descentralización de la atención vanguardista para tumores cerebrales en toda la regi...
-
ZAP Surgical Announces First ZAP-X Gyroscopic Radiosurgery Patient Treatments in Latin America
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the first patient treatments using its ZAP-X® Gyroscopic Radiosurgery® platform in Latin America. Located in Neuland, Boquerón, Paraguay, Radioterapia Concordia (www.saludconcordia.com) has officially commenced clinical use, marking a major milestone in the decentralization of state-of-the-art brain tumor care across the region. In its first day of operation, f...
-
Newly Published Health Economics Study Demonstrates In-Office Ear Tube Procedures with Hummingbird TTS Significantly Reduce Healthcare Costs
GOLDEN VALLEY, Minn.--(BUSINESS WIRE)--Preceptis Medical, Inc., a pioneer in pediatric ENT innovation, today announced the publication of a health economic study assessing the financial impact of shifting pediatric tympanostomy tube (ear tube) placement from operating room to in-office settings. The analysis, published in the Journal of Medical Economics, demonstrates significant cost savings potential for Commercial and Medicaid health insurance payers that provide access to in-office ear tube...
-
Pizza Nova and Partners Raise $64,179 for SickKids Foundation at 28th Annual Charity Golf Tournament
TORONTO--(BUSINESS WIRE)--Pizza Nova raised $64,179 at its 28th annual charity golf tournament held on June 17, in support of the SickKids Foundation....
-
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® (lenacapavir)—the company’s injectable HIV-1 capsid inhibitor—as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only twice-yearly option available in the United States for people who need or want PrEP. Data show that ≥99.9% of partici...
-
Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL
HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Saptalis Pharmaceuticals, LLC. is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective serotonin reuptake inhibitor (SSRI) developed to treat a range of mental health conditions effectively. This oral formulation is designed to support flexible and individualized treatment, particularly for patients who experience difficulty swallowing solid dosage forms. Fluoxetine Oral Solution is indicated for t...
-
Willis Knighton Health Live with 132 Clinics on MEDITECH Expanse
CANTON, Mass.--(BUSINESS WIRE)--Willis Knighton Health is live with MEDITECH Expanse in its 132 clinics....
-
Multi-Center NIH Research Trial Evaluating GALAD, a Novel Blood-Based Algorithm, in the Early Detection of Liver Cancer
LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced today that use of its AFP-L3 and DCP in vitro diagnostic tests is being evaluated in the National Liver Cancer Screening Trial (known as TRACER), a study funded by the National Cancer Institute, part of the National Institute of Health. The multi-center study compares liver cancer screening strategies in patients with cirrhosis or chronic hepa...